Vitas-M Laboratory
Vitas-M Laboratory (Vitas M Chemical Limited) is a Hong Kong-based, privately held supplier of small molecule screening compounds, building blocks, and fragment libraries for pharmaceutical, agrochemical, and academic drug discovery research, offering over 1.4 million compounds globally since 1998.
- Company typePrivate
- Founded1998
- HeadquartersCauseway Bay, Hong Kong SAR China
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Vitas-M Laboratory does
Vitas-M Laboratory, legally Vitas M Chemical Limited, is a privately held Hong Kong-based supplier of small molecule chemical compounds for pharmaceutical and agrochemical research and development. Founded in 1998 by Irina Haywood and operating from Causeway Bay with 11–50 employees, the company has built a catalog of over 1,400,000 individual synthetic organic screening compounds, plus 20,000+ organic building blocks, a Rule-of-3-compliant fragment collection (Allium), three diversity libraries (10,000, 37,000, and 55,000 compounds), and more than 50 disease- and target-specific targeted libraries generated using in-house clustering and similarity-based computational algorithms.
The core technology is a curated physical chemical inventory packaged with online discovery tools. Researchers can access the catalog through a 24/7 self-service database (downloadable without registration), a property-based molecular search engine (filtering on H-bond donors, acceptors, rotatable bonds, rings, PSA, LogP, and molecular weight), SDF creation, and availability checking. Compounds are shipped worldwide via FedEx and UPS in dry powder or DMSO formats, with comprehensive documentation (SD files, packing lists, MSDS). In-house algorithms design diversity libraries by grouping molecules via clustering for maximal chemical-space coverage and generate targeted libraries using reference-compound similarity thresholds above 0.85 with Rule-of-Five compliance.
The commercial model is direct-to-researcher catalog sales with a quote-based pricing system (no publicly disclosed prices) and a secondary tier of professional services for custom database generation. Customers span pharmaceutical companies (Gilead Sciences, Eisai, Mochida), government translational research (NCATS), and academic institutions (Uppsala, University of Michigan, Griffith University, University of Eastern Finland) across at least nine countries. GTM combines self-service product-led growth with a dedicated sales email ([email protected]) for enterprise and custom orders. Revenue is not publicly disclosed and the company is bootstrapped with no institutional investors, parent company, or M&A activity on record.
Vitas-M Laboratory firmographics
Firmographics- Name
- Vitas-M Laboratory
- Legal name
- Vitas M Chemical Limited
- Website
- https://vitasmlab.biz
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Vitas-M Laboratory (Vitas M Chemical Limited) is a Hong Kong-based, privately held supplier of small molecule screening compounds, building blocks, and fragment libraries for pharmaceutical, agrochemical, and academic drug discovery research, offering over 1.4 million compounds globally since 1998.
- Ownership category
- akta.pro rank
Vitas-M Laboratory industry classification
Industry- Product category
- Drug Discovery Chemical Compounds
- NAICS
- Medicinal and Botanical Manufacturing (325411)
- SIC
- Medicinal Chemicals & Botanical Products (2833)
- akta.pro primary industry
- Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL)
- akta.pro secondary industry
- High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA)
Keywords
Where Vitas-M Laboratory is headquartered
LocationHeadquarters
- HQ city
- Causeway Bay
- HQ country
- Hong Kong SAR China
- HQ region
- Asia
Markets served
Vitas-M Laboratory business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Infrastructure
Revenue model
- Screening Compounds Sales: Direct sale of individual screening compounds (STK/STL collection) in dry powder or DMSO formats. Full cherry-picking access to entire catalog of 1,400,000+ compounds for immediate delivery.
- Organic Building Blocks Sales: Sale of BBL collection containing 20,000+ synthetic organic building blocks for combinatorial chemistry and medicinal chemistry workflows. Available in pack sizes of 500mg, 1g, and 2g.
- Fragment Library Sales: Fragment-based drug discovery compounds (Allium collection) compliant with Rule of 3. Offered in various formats including 384-well plates and custom quantities.
- Special Database Downloads: Specialized diversity and targeted compound libraries available for download. Includes Diversity_Vitas-10000 (10,000 compounds), Diversity_Vitas-37000 (7,000 compounds), and Diversity_Vitas-55000 (55,000 compounds) plus disease-specific targeted libraries.
- Custom Compound Database Generation: Collaboration with expert scientific teams to generate specially tailored databases based on customer criteria for specific research needs.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Pay-as-you-go | Request for Quotation (RFQ) system for compound orders |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Vitas-M Laboratory product offering
Product offeringCore offering
Vitas-M Laboratory supplies synthetic organic screening compounds, fragment libraries, and building blocks for small molecule drug discovery in the pharmaceutical and agrochemical industries. It offers a catalog of over 1,400,000 individual compounds along with diversity and disease-specific targeted libraries, delivered via self-service online download and direct courier shipping.
Product overview
Vitas-M Laboratory operates as a chemical compound supplier offering multiple product collections that serve as foundational research tools for pharmaceutical and agrochemical drug discovery. The core portfolio consists of the STK/STL screening compounds collection (1,400,000+ compounds) for biological assays and hit identification, the BBL building blocks collection (20,000+ compounds) for combinatorial and medicinal chemistry synthesis, and the Allium fragment collection for fragment-based drug discovery. These foundational products are complemented by specialized databases including three diversity libraries (Diversity_Vitas-10000, Diversity_Vitas-37000, Diversity_Vitas-55000) that provide structurally diverse compound sets with up to 55,000 molecules, and over 50 disease/target-specific targeted libraries designed using computational algorithms. The company provides online search tools, downloadable SDF files, and multiple delivery formats (dry powder, DMSO solutions, plates) to support researchers across the drug discovery workflow.
Differentiator
Problem solved
Functional benefit
Brands
- STK: Stock screening compounds for biological assays and hit identification
- BBL
- Allium
- Diversity_Vitas-10000
- Diversity_Vitas-37000
- Diversity_Vitas-55000
Products and services
- STK/STL Collection (Screening Compounds) Stock of over 1,400,000 synthetic organic screening compounds available for immediate delivery, suitable for high-throughput screening, lead optimization, and medicinal chemistry workflows. Available in dry powder or DMSO solution formats.
- Allium Fragment Collection Stock of fragments for Fragment Based Drug Discovery, compiled on the basis of Rule of 3 (Molecular weight < 300, ClogP < 3, H-bond donors < 3, H-bond acceptors < 3) and proprietary filters. Available as dry powder or DMSO solutions in various formats including 384-well plates.
- BBL Collection (Building Blocks) Collection of more than 20,000 organic building blocks for combinatorial chemistry and medicinal chemistry workflows. Available as dry powder in 500mg, 1g and 2g pack sizes.
- Diversity_Vitas-10000 Diversity library of 10,000 compounds designed for smaller-scale screening assays, emphasizing structural diversity using advanced clustering algorithms that group molecules by structural similarity.
- Diversity_Vitas-37000 Expanded diversity collection of 7,000 compounds offering greater variety of pharmacophores and structural motifs for medium- to high-throughput screening efforts.
- Diversity_Vitas-55000 Diversity library of 55,000 compounds incorporating wildcard molecules with unique or unconventional structures excluded from smaller libraries, designed for phenotypic screening and fragment-based discovery.
- Targeted Libraries (disease/target-specific) Over 50 targeted molecular libraries designed using computational algorithms based on similarities with known active compounds. Libraries include Alzheimer's Disease, Cancer, Kinases, Ion Channels, and GPCRs, all following Rule-of-Five with >0.85 similarity to reference compounds.
- Custom Compound Database Generation Collaboration with expert scientific teams to generate specially tailored databases based on customer criteria for specific research needs.
Quantifiable outcome
- Over 1.4 million compounds available for immediate shipment
- +2 more outcomes
Companies that use Vitas-M Laboratory
Customer profileNamed customers10 records
Segments4 records
Ideal customer profiles3 records
Vitas-M Laboratory technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Vitas-M Laboratory partnerships and signals
Strategic signalScale indicators6 records
Recent moves6 records
Expansion highlights5 records
Vitas-M Laboratory competitors and assessment
Company assessmentBroad incumbents
- WuXi AppTec: WuXi AppTec is a large CRO/CDMO with a compound supply and screening library business alongside broader discovery services. Comparable to Vitas-M in compound supply but operates at much greater scale and broader service scope, often chosen by pharma seeking integrated discovery outsourcing.
- Sigma-Aldrich (Merck): Sigma-Aldrich / MilliporeSigma is the broad incumbent life science reagent supplier offering screening compounds, building blocks, and fragment libraries as part of a much larger catalog. Competes with Vitas-M on procurement lists for pharma and academic customers but does not specialize in curated screening collections.
Direct peers
- AK Scientific: AK Scientific supplies building blocks, intermediates, and screening compounds globally via catalog and custom synthesis. Comparable to Vitas-M's BBL and STK offerings in customer base, product format options, and online ordering model.
- Combi-Blocks: Combi-Blocks manufactures and supplies organic building blocks and screening compounds for medicinal chemistry, with a focus on combinatorial and parallel synthesis. Direct competitor to Vitas-M's BBL building blocks offering and a frequent alternate source on pharma RFQs.
- MolPort: MolPort operates a chemical compound marketplace aggregating suppliers worldwide, with online search and order routing. Comparable to Vitas-M in serving medicinal chemists sourcing screening compounds and building blocks across pharma and academia.
- Life Chemicals: Life Chemicals supplies screening libraries, focused/targeted libraries, and building blocks for HTS and medicinal chemistry. Direct competitor to Vitas-M across STK-style collections, targeted libraries, and custom compound requests from pharma and academic clients.
- Specs: Specs is a long-standing compound library supplier offering screening compounds, building blocks, and target-focused libraries from the Netherlands. Closely comparable to Vitas-M in catalog type, customer base (pharma + academia), and historical footprint in European pharma procurement.
- Enamine: Enamine is the largest independent supplier of screening compounds and building blocks, with a catalog of several million molecules and in-house manufacturing capabilities. Directly comparable to Vitas-M's STK and BBL collections and frequently head-to-head on pharma procurement RFQs.
- Otava Chemicals: Otava offers small molecule screening libraries, focused/targeted libraries, and building blocks for drug discovery. Comparable product mix to Vitas-M across screening compounds and specialty libraries serving biotech and academic customers.
- ChemSpace: ChemSpace is an online marketplace and aggregator offering tens of millions of screening compounds and building blocks with self-service ordering. Competes with Vitas-M on catalog breadth, online UX, and global delivery for pharma and academic researchers.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Vitas-M Laboratory social profiles
Digital presenceVitas-M Laboratory financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vitas-M Laboratory leadership team
Management profileNumber of profiles
Profiles1 record
Vitas-M Laboratory funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vitas-M Laboratory M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vitas-M Laboratory
What does Vitas-M Laboratory do?
Vitas-M Laboratory supplies synthetic organic screening compounds, fragment libraries, and building blocks for small molecule drug discovery in the pharmaceutical and agrochemical industries. It offers a catalog of over 1,400,000 individual compounds along with diversity and disease-specific targeted libraries, delivered via self-service online download and direct courier shipping.
Is Vitas-M Laboratory a public or private company?
Vitas-M Laboratory is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Vitas-M Laboratory founded?
Vitas-M Laboratory was founded in 1998. It employs 11 to 50 people.
Where is Vitas-M Laboratory based?
Vitas-M Laboratory is headquartered in Causeway Bay, Hong Kong SAR China, in the Asia region.
How does Vitas-M Laboratory make money?
Five revenue lines are on record. Screening Compounds Sales are the primary driver. The others are organic Building Blocks Sales, fragment Library Sales, special Database Downloads and custom Compound Database Generation.
Who are Vitas-M Laboratory's main competitors?
Broad incumbents on record are WuXi AppTec and Sigma-Aldrich (Merck). Direct peers are AK Scientific, Combi-Blocks, MolPort, Life Chemicals, Specs, Enamine, Otava Chemicals and ChemSpace.
Does Vitas-M Laboratory have an API?
No public API is recorded for Vitas-M Laboratory.
What industry is Vitas-M Laboratory in?
Vitas-M Laboratory's product category is Drug Discovery Chemical Compounds. Its primary akta.pro industry code is HLAAAIAL, Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries), with a secondary code of HLAAAIAA, High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening). Its NAICS code is 325411 and its SIC code is 2833.